Product Name

  • Name

    3-MORPHOLINONE, 4-[4-[(5S)-5-(AMINOMETHYL)-2-OXO-3-OXAZOLIDINYL]PHENYL]-

  • EINECS 692-970-2
  • CAS No. 446292-10-0
  • Article Data39
  • CAS DataBase
  • Density 1.348 g/cm3
  • Solubility
  • Melting Point 148.3-149.8 °C
  • Formula C14H17N3O4
  • Boiling Point 580.4 °C at 760 mmHg
  • Molecular Weight 291.307
  • Flash Point 304.8 °C
  • Transport Information
  • Appearance White solid
  • Safety
  • Risk Codes
  • Molecular Structure Molecular Structure of 446292-10-0 (3-MORPHOLINONE, 4-[4-[(5S)-5-(AMINOMETHYL)-2-OXO-3-OXAZOLIDINYL]PHENYL]-)
  • Hazard Symbols
  • Synonyms (S)-4-(4-(5-(Aminomethyl)-2-oxooxazolidin-3-yl)phenyl)morpholin-3-one;
  • PSA 85.10000
  • LogP 1.16400

Synthetic route

4-{4-[(5S)-5-((dibenzylamino)methyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl}morpholin-3-one
1372665-04-7

4-{4-[(5S)-5-((dibenzylamino)methyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl}morpholin-3-one

4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one
446292-10-0

4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one

Conditions
ConditionsYield
With palladium on activated charcoal; hydrogen In methanol at 40 - 50℃; under 37503.8 Torr; for 20h; Solvent; Reagent/catalyst;100%
With palladium 10% on activated carbon; hydrogen In ethyl acetate at 50℃; for 18h; Inert atmosphere;92.6%
With palladium 10% on activated carbon; hydrogen; acetic acid In methanol at 50℃; under 4200.42 Torr;2.56 g
4-{4-[(S)-5-[(((4-chlorophenyl)methylene)amino)methyl]-2-oxo-1,3-oxazolidin-3-yl]phenyl}-morpholin-3-one
1414932-72-1

4-{4-[(S)-5-[(((4-chlorophenyl)methylene)amino)methyl]-2-oxo-1,3-oxazolidin-3-yl]phenyl}-morpholin-3-one

4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one
446292-10-0

4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one

Conditions
ConditionsYield
With isobutylamine In toluene for 3h; Product distribution / selectivity; Reflux;99.7%
With isobutylamine In toluene for 3h; Concentration; Solvent; Time; Temperature; Reagent/catalyst; Heating; Reflux;99.7%
With hydrogenchloride; triethylamine In ethanol; water at 22 - 65℃; for 1h;95%
With hydrogenchloride In water for 0.333333h; Time;
4-{4-[(5S)-5-(amino methyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl}morpholin-3-one hydrochloride
898543-06-1

4-{4-[(5S)-5-(amino methyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl}morpholin-3-one hydrochloride

4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one
446292-10-0

4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one

Conditions
ConditionsYield
In dichloromethane; water pH=8; Concentration;96.7%
With potassium carbonate In methanol at 25 - 30℃; for 0.5h;56%
With potassium carbonate In methanol at 25 - 30℃; for 0.5h;56%
With potassium carbonate In water at 20℃; for 2h;
2-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-1,3-oxazolidin-5-yl}methyl)-1H-isoindole-1,3(2H)-dione
446292-08-6

2-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-1,3-oxazolidin-5-yl}methyl)-1H-isoindole-1,3(2H)-dione

4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one
446292-10-0

4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one

Conditions
ConditionsYield
With hydrazine hydrate In methanol at 80℃; for 2.5h;96.1%
With ethanolamine In toluene at 75 - 85℃; for 2h; Solvent; Temperature;95.87%
With hydrazine hydrate In ethanol for 2h; Reflux;95.4%
4-{4-[(5R)-5-(azidomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl}-morpholin-3-one
1349248-79-8

4-{4-[(5R)-5-(azidomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl}-morpholin-3-one

4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one
446292-10-0

4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one

Conditions
ConditionsYield
With 5%-palladium/activated carbon; hydrogen In ethanol at 40℃; for 24h;96%
With 5%-palladium/activated carbon; hydrogen In ethyl acetate for 12h;91%
With palladium 10% on activated carbon; hydrogen In methanol under 1500.15 - 3000.3 Torr; for 4h;90.9%
With 5%-palladium/activated carbon; hydrogen In ethyl acetate at 45℃; under 3750.38 - 6000.6 Torr; for 8h; Autoclave;80%
With water; triphenylphosphine In tetrahydrofuran at 10 - 65℃;18 g
2-((2R)-2-hydroxy-3-{[4-(3-oxo-4-morpholinyl)phenyl]amino}propyl)-1H-isoindole-1,3(2H)-dione
446292-07-5

2-((2R)-2-hydroxy-3-{[4-(3-oxo-4-morpholinyl)phenyl]amino}propyl)-1H-isoindole-1,3(2H)-dione

methylamine
74-89-5

methylamine

4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one
446292-10-0

4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one

Conditions
ConditionsYield
Stage #1: 2-((2S)-2-hydroxy-3-{[4-(3-oxomorpholin-4-yl)phenyl]amino}propyl)-1H-isoindole-1,3(2H)-dione With dmap; 1,1'-carbonyldiimidazole In tetrahydrofuran for 12h; Reflux;
Stage #2: methylamine In ethanol; water for 8h; Reflux;
92.2%
tert-butyl {(5S)-3-[4-(3-oxo-4-morpholinyl)phenyl]-2-oxo-1,3-oxazolidin-5-yl}methylcarbamate
1416129-92-4

tert-butyl {(5S)-3-[4-(3-oxo-4-morpholinyl)phenyl]-2-oxo-1,3-oxazolidin-5-yl}methylcarbamate

4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one
446292-10-0

4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one

Conditions
ConditionsYield
With hydrogenchloride; water In ethanol at 20℃; for 24h; Solvent;90%
With hydrogenchloride In ethanol; water at 20℃; for 24h; Solvent;90%
(S)-4-(4-{5-[(benzylidene-amino)-methyl]-2-oxo-oxazolidine-3-yl}-phenyl)-morpholin-3-one
1414932-73-2

(S)-4-(4-{5-[(benzylidene-amino)-methyl]-2-oxo-oxazolidine-3-yl}-phenyl)-morpholin-3-one

4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one
446292-10-0

4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one

Conditions
ConditionsYield
With hydrogenchloride; water In ethanol at 20℃; for 24h; Solvent;90%
With hydrogenchloride In ethanol; water at 20℃; for 24h; Solvent; Time;90%
C14H14N2O5

C14H14N2O5

4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one
446292-10-0

4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one

Conditions
ConditionsYield
Stage #1: C14H14N2O5 With ammonium hydroxide In methanol for 0.5h;
Stage #2: With methanol; sodium tetrahydroborate at 0 - 20℃; for 2.5h;
87.5%
2-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-1,3-oxazolidin-5-yl}methyl)-1H-isoindole-1,3(2H)-dione
446292-08-6

2-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-1,3-oxazolidin-5-yl}methyl)-1H-isoindole-1,3(2H)-dione

methylamine
74-89-5

methylamine

4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one
446292-10-0

4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one

Conditions
ConditionsYield
In methanol; water for 2h; Reflux;85%
2-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-1,3-oxazolidin-5-yl}methyl)-1H-isoindole-1,3(2H)-dione
446292-08-6

2-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-1,3-oxazolidin-5-yl}methyl)-1H-isoindole-1,3(2H)-dione

A

4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one
446292-10-0

4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one

B

2,3-dihydrophthalazine-1,4-dione
1445-69-8

2,3-dihydrophthalazine-1,4-dione

Conditions
ConditionsYield
With hydrazine hydrate In ethanol at 65℃; for 3h;A 73%
B 12.7%
2-((2R)-2-hydroxy-3-{[4-(3-oxo-4-morpholinyl)phenyl]amino}propyl)-1H-isoindole-1,3(2H)-dione
446292-07-5

2-((2R)-2-hydroxy-3-{[4-(3-oxo-4-morpholinyl)phenyl]amino}propyl)-1H-isoindole-1,3(2H)-dione

4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one
446292-10-0

4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 87 percent / 4-(dimethylamino)pyridine / tetrahydrofuran / 24 h / 60 °C
2: aq. MeNH2 / ethanol / 1 h / Heating
View Scheme
Multi-step reaction with 2 steps
1.1: toluene / 3 h / Industry scale; Reflux
2.1: methylamine / ethanol / 4 h / 65 °C / Industry scale
2.2: 58 - 60 °C / pH 2.7 / Industry scale
View Scheme
Multi-step reaction with 2 steps
1: dichloromethane / 20 h / 30 °C
2: hydrazine hydrate / methanol / 1 h / Reflux
View Scheme
4-(4-aminophenyl)morpholin-3-one
438056-69-0

4-(4-aminophenyl)morpholin-3-one

4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one
446292-10-0

4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 92 percent / ethanol; H2O / 27 h / Heating
2: 87 percent / 4-(dimethylamino)pyridine / tetrahydrofuran / 24 h / 60 °C
3: aq. MeNH2 / ethanol / 1 h / Heating
View Scheme
Multi-step reaction with 3 steps
1.1: water / ethanol / 36 h / 60 °C / Industry scale
2.1: toluene / 3 h / Industry scale; Reflux
3.1: methylamine / ethanol / 4 h / 65 °C / Industry scale
3.2: 58 - 60 °C / pH 2.7 / Industry scale
View Scheme
Multi-step reaction with 4 steps
1: toluene / 20 °C / Reflux
2: MgI2*etherate / tetrahydrofuran / 20 - 80 °C / Inert atmosphere
3: sodium azide / N,N-dimethyl-formamide / 12 h / 85 °C
4: 5%-palladium/activated carbon; hydrogen / ethyl acetate / 12 h
View Scheme
2-Anilinoethanol
122-98-5

2-Anilinoethanol

4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one
446292-10-0

4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one

Conditions
ConditionsYield
Multi-step reaction with 6 steps
1.1: sodium hydroxide / ethanol; water / 0.5 h / 38 - 45 °C / pH 10 - 13 / Industry scale
2.1: nitric acid; sulfuric acid / sulfolane / 2 h / -5 - 30 °C
3.1: hydrogen / Raney Ni / methanol / 24 h / 40 - 50 °C
4.1: water / ethanol / 36 h / 60 °C / Industry scale
5.1: toluene / 3 h / Industry scale; Reflux
6.1: methylamine / ethanol / 4 h / 65 °C / Industry scale
6.2: 58 - 60 °C / pH 2.7 / Industry scale
View Scheme
Multi-step reaction with 7 steps
1: sodium hydroxide / ethanol; water
2: sulfuric acid; nitric acid / water
3: 5%-palladium/activated carbon; hydrogen / ethanol / 40 °C
4: toluene / 20 °C / Reflux
5: MgI2*etherate / tetrahydrofuran / 20 - 80 °C / Inert atmosphere
6: sodium azide / N,N-dimethyl-formamide / 12 h / 85 °C
7: 5%-palladium/activated carbon; hydrogen / ethyl acetate / 12 h
View Scheme
4-(4-nitrophenyl)-3-morpholinone
446292-04-2

4-(4-nitrophenyl)-3-morpholinone

4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one
446292-10-0

4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1.1: hydrogen / Raney Ni / methanol / 24 h / 40 - 50 °C
2.1: water / ethanol / 36 h / 60 °C / Industry scale
3.1: toluene / 3 h / Industry scale; Reflux
4.1: methylamine / ethanol / 4 h / 65 °C / Industry scale
4.2: 58 - 60 °C / pH 2.7 / Industry scale
View Scheme
Multi-step reaction with 5 steps
1: 5%-palladium/activated carbon; hydrogen / ethanol / 40 °C
2: toluene / 20 °C / Reflux
3: MgI2*etherate / tetrahydrofuran / 20 - 80 °C / Inert atmosphere
4: sodium azide / N,N-dimethyl-formamide / 12 h / 85 °C
5: 5%-palladium/activated carbon; hydrogen / ethyl acetate / 12 h
View Scheme
Multi-step reaction with 4 steps
1: ammonium formate / water / 30 - 90 °C
2: water / 8 h / 80 °C
3: dmap / 6 h / 80 - 85 °C
4: methylamine / water / 5 h / 35 °C
View Scheme
4-phenyl-3-morpholinone
29518-11-4

4-phenyl-3-morpholinone

4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one
446292-10-0

4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1.1: nitric acid; sulfuric acid / sulfolane / 2 h / -5 - 30 °C
2.1: hydrogen / Raney Ni / methanol / 24 h / 40 - 50 °C
3.1: water / ethanol / 36 h / 60 °C / Industry scale
4.1: toluene / 3 h / Industry scale; Reflux
5.1: methylamine / ethanol / 4 h / 65 °C / Industry scale
5.2: 58 - 60 °C / pH 2.7 / Industry scale
View Scheme
Multi-step reaction with 6 steps
1: sulfuric acid; nitric acid / water
2: 5%-palladium/activated carbon; hydrogen / ethanol / 40 °C
3: toluene / 20 °C / Reflux
4: MgI2*etherate / tetrahydrofuran / 20 - 80 °C / Inert atmosphere
5: sodium azide / N,N-dimethyl-formamide / 12 h / 85 °C
6: 5%-palladium/activated carbon; hydrogen / ethyl acetate / 12 h
View Scheme
4-{4-[(5R)-5-(chloromethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl}morpholin-3-one
1252018-28-2

4-{4-[(5R)-5-(chloromethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl}morpholin-3-one

4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one
446292-10-0

4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: sodium azide / N,N-dimethyl-formamide / 12 h / 85 °C
2: 5%-palladium/activated carbon; hydrogen / ethyl acetate / 12 h
View Scheme
Multi-step reaction with 2 steps
1: N,N-dimethyl-formamide / 5 h / Reflux
2: hydrazine hydrate / methanol / 1 h / Reflux
View Scheme
4-(4-isocyanatophenyl)morpholin-3-one
1325210-64-7

4-(4-isocyanatophenyl)morpholin-3-one

4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one
446292-10-0

4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: MgI2*etherate / tetrahydrofuran / 20 - 80 °C / Inert atmosphere
2: sodium azide / N,N-dimethyl-formamide / 12 h / 85 °C
3: 5%-palladium/activated carbon; hydrogen / ethyl acetate / 12 h
View Scheme
Multi-step reaction with 2 steps
1: lithium bromide; Triphenylphosphine oxide / 1-methyl-pyrrolidin-2-one / 7 h / 90 - 95 °C
2: potassium hydroxide / water / Reflux
View Scheme
4-[4-(N-(3-chloro-(2R)-2-hydroxy-1-propyl)amino)phenyl]morpholin-3-one
1252018-10-2

4-[4-(N-(3-chloro-(2R)-2-hydroxy-1-propyl)amino)phenyl]morpholin-3-one

4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one
446292-10-0

4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: dichloromethane / 20 h / 30 °C
2: N,N-dimethyl-formamide / 5 h / Reflux
3: hydrazine hydrate / methanol / 1 h / Reflux
View Scheme
Multi-step reaction with 3 steps
1: chloroform / 20 h / 30 °C
2: N,N-dimethyl-formamide / 5 h / Reflux
3: hydrazine hydrate / methanol / 1 h / Reflux
View Scheme
Multi-step reaction with 3 steps
1: N,N-dimethyl-formamide / 5 h / Reflux
2: dichloromethane / 20 h / 30 °C
3: hydrazine hydrate / methanol / 1 h / Reflux
View Scheme
[4-(3-oxo-morpholin-4-yl)phenyl]carbamic acid benzyl ester
1313613-18-1

[4-(3-oxo-morpholin-4-yl)phenyl]carbamic acid benzyl ester

4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one
446292-10-0

4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: lithium tert-butoxide / dichloromethane / 24 h / Reflux
2: isobutylamine / toluene / 3 h / Reflux
View Scheme
Multi-step reaction with 4 steps
1.1: lithium tert-butoxide; methanol / tetrahydrofuran; N,N-dimethyl-formamide / 0.17 h / 0 °C
1.2: 18 h / 30 °C
2.1: triethylamine / dichloromethane / 18 h / 0 - 20 °C
3.1: sodium carbonate / N,N-dimethyl-formamide / 2 h / 90 °C
4.1: palladium 10% on activated carbon; hydrogen / ethyl acetate / 18 h / 50 °C / Inert atmosphere
View Scheme
Multi-step reaction with 4 steps
1.1: lithium tert-butoxide; methanol / tetrahydrofuran; N,N-dimethyl-formamide / 0.17 h / 0 °C
1.2: 18 h / 30 °C
2.1: triethylamine / dichloromethane / 18 h / 0 - 20 °C
3.1: sodium azide / N,N-dimethyl-formamide / 4 h / 80 - 85 °C
4.1: palladium 10% on activated carbon; hydrogen / methanol / 4 h / 1500.15 - 3000.3 Torr
View Scheme
dodecyl (4-(3-oxomorpholin)phenyl)carbamate
1414932-71-0

dodecyl (4-(3-oxomorpholin)phenyl)carbamate

4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one
446292-10-0

4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: lithium tert-butoxide / dichloromethane / 36 h / Reflux
2: isobutylamine / toluene / 3 h / Reflux
View Scheme
Multi-step reaction with 2 steps
1: n-butyllithium / dichloromethane / 36 h / Heating; Reflux
2: isobutylamine / toluene / 3 h / Heating; Reflux
View Scheme
4-{4-[(5S)-5-(N-benzylaminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl}morphoIin-3-one
1424942-78-8

4-{4-[(5S)-5-(N-benzylaminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl}morphoIin-3-one

4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one
446292-10-0

4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one

Conditions
ConditionsYield
With 5%-palladium/activated carbon; hydrogen; acetic acid In methanol at 45℃; under 3750.38 - 6000.6 Torr; for 8h; Autoclave;15.5 g
4-[4-{(R)-2,3-dihydroxy-propylamino}phenyl]morpholin-3-one
1447919-65-4

4-[4-{(R)-2,3-dihydroxy-propylamino}phenyl]morpholin-3-one

4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one
446292-10-0

4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1.1: methanol / 48 h / 30 °C
1.2: 2 h / Reflux
2.1: triethylamine / dichloromethane / 18 h / 0 - 20 °C
3.1: sodium carbonate / N,N-dimethyl-formamide / 2 h / 90 °C
4.1: palladium 10% on activated carbon; hydrogen / ethyl acetate / 18 h / 50 °C / Inert atmosphere
View Scheme
Multi-step reaction with 4 steps
1.1: methanol / 48 h / 30 °C
1.2: 2 h / Reflux
2.1: triethylamine / dichloromethane / 18 h / 0 - 20 °C
3.1: sodium azide / N,N-dimethyl-formamide / 4 h / 80 - 85 °C
4.1: palladium 10% on activated carbon; hydrogen / methanol / 4 h / 1500.15 - 3000.3 Torr
View Scheme
Multi-step reaction with 4 steps
1: triethylamine / chloroform / 1 h / -5 °C
2: N-ethyl-N,N-diisopropylamine / N,N-dimethyl-formamide / 10 h / 80 °C
3: sodium azide / water; N,N-dimethyl-formamide / 10 h / 0 - 40 °C
4: 5%-palladium/activated carbon; hydrogen / ethanol / 24 h / 40 °C
View Scheme
butyric acid-2(R)-2-hydroxy-3-[4-(3-oxo-morpholin-4-yl)phenylamino]-propyl ester
1446022-14-5

butyric acid-2(R)-2-hydroxy-3-[4-(3-oxo-morpholin-4-yl)phenylamino]-propyl ester

4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one
446292-10-0

4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1.1: methanol / 48 h / 30 °C
1.2: 2 h / Reflux
2.1: triethylamine / dichloromethane / 18 h / 0 - 20 °C
3.1: sodium carbonate / N,N-dimethyl-formamide / 2 h / 90 °C
4.1: palladium 10% on activated carbon; hydrogen / ethyl acetate / 18 h / 50 °C / Inert atmosphere
View Scheme
Multi-step reaction with 4 steps
1.1: methanol / 48 h / 30 °C
1.2: 2 h / Reflux
2.1: triethylamine / dichloromethane / 18 h / 0 - 20 °C
3.1: sodium azide / N,N-dimethyl-formamide / 4 h / 80 - 85 °C
4.1: palladium 10% on activated carbon; hydrogen / methanol / 4 h / 1500.15 - 3000.3 Torr
View Scheme
Multi-step reaction with 5 steps
1: dichloromethane / 48 h / 30 °C
2: sodium methylate; methanol / 1 h / 30 °C
3: triethylamine / dichloromethane / 18 h / 0 - 20 °C
4: sodium carbonate / N,N-dimethyl-formamide / 2 h / 90 °C
5: palladium 10% on activated carbon; hydrogen / ethyl acetate / 18 h / 50 °C / Inert atmosphere
View Scheme
Multi-step reaction with 5 steps
1: dichloromethane / 48 h / 30 °C
2: sodium methylate; methanol / 1 h / 30 °C
3: triethylamine / dichloromethane / 18 h / 0 - 20 °C
4: sodium azide / N,N-dimethyl-formamide / 4 h / 80 - 85 °C
5: palladium 10% on activated carbon; hydrogen / methanol / 4 h / 1500.15 - 3000.3 Torr
View Scheme
butyric acid-2-oxo-5(R)-3-[4-(3-oxomorpholin-4-yl)-phenyl]oxazolidin-5-yl-methyl ester
1446022-15-6

butyric acid-2-oxo-5(R)-3-[4-(3-oxomorpholin-4-yl)-phenyl]oxazolidin-5-yl-methyl ester

4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one
446292-10-0

4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: sodium methylate; methanol / 1 h / 30 °C
2: triethylamine / dichloromethane / 18 h / 0 - 20 °C
3: sodium carbonate / N,N-dimethyl-formamide / 2 h / 90 °C
4: palladium 10% on activated carbon; hydrogen / ethyl acetate / 18 h / 50 °C / Inert atmosphere
View Scheme
Multi-step reaction with 4 steps
1: sodium methylate; methanol / 1 h / 30 °C
2: triethylamine / dichloromethane / 18 h / 0 - 20 °C
3: sodium azide / N,N-dimethyl-formamide / 4 h / 80 - 85 °C
4: palladium 10% on activated carbon; hydrogen / methanol / 4 h / 1500.15 - 3000.3 Torr
View Scheme
4-(4-((R)-5-benzyloxymethyl-2-oxo-oxazolidin-3-yl)phenyl)morpholin-3-one
1117893-59-0

4-(4-((R)-5-benzyloxymethyl-2-oxo-oxazolidin-3-yl)phenyl)morpholin-3-one

4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one
446292-10-0

4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: palladium 10% on activated carbon; hydrogen / ethanol / 20 °C / 3000.3 - 3750.38 Torr / Autoclave
2: triethylamine / dichloromethane / 18 h / 0 - 20 °C
3: sodium carbonate / N,N-dimethyl-formamide / 2 h / 90 °C
4: palladium 10% on activated carbon; hydrogen / ethyl acetate / 18 h / 50 °C / Inert atmosphere
View Scheme
Multi-step reaction with 4 steps
1: palladium 10% on activated carbon; hydrogen / ethanol / 20 °C / 3000.3 - 3750.38 Torr / Autoclave
2: triethylamine / dichloromethane / 18 h / 0 - 20 °C
3: sodium azide / N,N-dimethyl-formamide / 4 h / 80 - 85 °C
4: palladium 10% on activated carbon; hydrogen / methanol / 4 h / 1500.15 - 3000.3 Torr
View Scheme
4-(4-(R)-3-benzyloxy-2-hydroxy-propylamino)phenyl-morpholin-3-one
1117893-58-9

4-(4-(R)-3-benzyloxy-2-hydroxy-propylamino)phenyl-morpholin-3-one

4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one
446292-10-0

4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: dichloromethane / 44 h / 30 °C
2: palladium 10% on activated carbon; hydrogen / ethanol / 20 °C / 3000.3 - 3750.38 Torr / Autoclave
3: triethylamine / dichloromethane / 18 h / 0 - 20 °C
4: sodium carbonate / N,N-dimethyl-formamide / 2 h / 90 °C
5: palladium 10% on activated carbon; hydrogen / ethyl acetate / 18 h / 50 °C / Inert atmosphere
View Scheme
Multi-step reaction with 5 steps
1: dichloromethane / 44 h / 30 °C
2: palladium 10% on activated carbon; hydrogen / ethanol / 20 °C / 3000.3 - 3750.38 Torr / Autoclave
3: triethylamine / dichloromethane / 18 h / 0 - 20 °C
4: sodium azide / N,N-dimethyl-formamide / 4 h / 80 - 85 °C
5: palladium 10% on activated carbon; hydrogen / methanol / 4 h / 1500.15 - 3000.3 Torr
View Scheme
acetic acid-1-benzyloxymethyl-2-[(R)-4-(3-oxo-morpholin-4-yl)phenylamino]-ethylester
1447919-68-7

acetic acid-1-benzyloxymethyl-2-[(R)-4-(3-oxo-morpholin-4-yl)phenylamino]-ethylester

4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one
446292-10-0

4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one

Conditions
ConditionsYield
Multi-step reaction with 6 steps
1: chloroform / 2 h / 50 °C
2: lithium tert-butoxide; methanol / tetrahydrofuran; N,N-dimethyl-formamide / 2 h / 0 °C
3: palladium 10% on activated carbon; hydrogen / ethanol / 20 °C / 3000.3 - 3750.38 Torr / Autoclave
4: triethylamine / dichloromethane / 18 h / 0 - 20 °C
5: sodium carbonate / N,N-dimethyl-formamide / 2 h / 90 °C
6: palladium 10% on activated carbon; hydrogen / ethyl acetate / 18 h / 50 °C / Inert atmosphere
View Scheme
Multi-step reaction with 6 steps
1: chloroform / 2 h / 50 °C
2: lithium tert-butoxide; methanol / tetrahydrofuran; N,N-dimethyl-formamide / 2 h / 0 °C
3: palladium 10% on activated carbon; hydrogen / ethanol / 20 °C / 3000.3 - 3750.38 Torr / Autoclave
4: triethylamine / dichloromethane / 18 h / 0 - 20 °C
5: sodium azide / N,N-dimethyl-formamide / 4 h / 80 - 85 °C
6: palladium 10% on activated carbon; hydrogen / methanol / 4 h / 1500.15 - 3000.3 Torr
View Scheme
acetic acid-1-benzyloxymethyl-2-{[(R)-(3-oxo-morpholin-4-yl)-phenyl]-chlorocarbonyl-amino} ethyl ester
1447919-69-8

acetic acid-1-benzyloxymethyl-2-{[(R)-(3-oxo-morpholin-4-yl)-phenyl]-chlorocarbonyl-amino} ethyl ester

4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one
446292-10-0

4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: lithium tert-butoxide; methanol / tetrahydrofuran; N,N-dimethyl-formamide / 2 h / 0 °C
2: palladium 10% on activated carbon; hydrogen / ethanol / 20 °C / 3000.3 - 3750.38 Torr / Autoclave
3: triethylamine / dichloromethane / 18 h / 0 - 20 °C
4: sodium carbonate / N,N-dimethyl-formamide / 2 h / 90 °C
5: palladium 10% on activated carbon; hydrogen / ethyl acetate / 18 h / 50 °C / Inert atmosphere
View Scheme
Multi-step reaction with 5 steps
1: lithium tert-butoxide; methanol / tetrahydrofuran; N,N-dimethyl-formamide / 2 h / 0 °C
2: palladium 10% on activated carbon; hydrogen / ethanol / 20 °C / 3000.3 - 3750.38 Torr / Autoclave
3: triethylamine / dichloromethane / 18 h / 0 - 20 °C
4: sodium azide / N,N-dimethyl-formamide / 4 h / 80 - 85 °C
5: palladium 10% on activated carbon; hydrogen / methanol / 4 h / 1500.15 - 3000.3 Torr
View Scheme
4-(4-((R)-5-((phenyloxycarbonyloxy)methyl)-2-oxo-oxazolidin-3-yl)phenyl)-morpholin-3-one
1447919-71-2

4-(4-((R)-5-((phenyloxycarbonyloxy)methyl)-2-oxo-oxazolidin-3-yl)phenyl)-morpholin-3-one

4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one
446292-10-0

4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: sodium methylate; methanol / 4 h / 30 °C
2: triethylamine / dichloromethane / 18 h / 0 - 20 °C
3: sodium carbonate / N,N-dimethyl-formamide / 2 h / 90 °C
4: palladium 10% on activated carbon; hydrogen / ethyl acetate / 18 h / 50 °C / Inert atmosphere
View Scheme
Multi-step reaction with 4 steps
1: sodium methylate; methanol / 4 h / 30 °C
2: triethylamine / dichloromethane / 18 h / 0 - 20 °C
3: sodium azide / N,N-dimethyl-formamide / 4 h / 80 - 85 °C
4: palladium 10% on activated carbon; hydrogen / methanol / 4 h / 1500.15 - 3000.3 Torr
View Scheme
4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one
446292-10-0

4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one

5-chlorothiophene-2-carbonyl chloride
42518-98-9

5-chlorothiophene-2-carbonyl chloride

Rivaroxaban
366789-02-8

Rivaroxaban

Conditions
ConditionsYield
With triethylamine In tetrahydrofuran at 20℃; for 3h; Product distribution / selectivity;100%
With triethylamine In tetrahydrofuran at 20℃; for 3h; Reagent/catalyst; Solvent; Time; Concentration; Temperature;100%
With sodium carbonate In water; acetone; toluene at 8 - 53℃; for 0.5h;98.7%
4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one
446292-10-0

4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one

formic acid
64-18-6

formic acid

N-({(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)formamide
1616563-62-2

N-({(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)formamide

Conditions
ConditionsYield
In toluene at 110 - 120℃; Solvent;96%
4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one
446292-10-0

4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one

2-Thiophenecarbonyl chloride
5271-67-0

2-Thiophenecarbonyl chloride

N-({(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophene-2-carboxamide

N-({(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophene-2-carboxamide

Conditions
ConditionsYield
With 4-methyl-morpholine In water; acetonitrile at -5 - 20℃; for 2.5h; Reagent/catalyst;96%
4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one
446292-10-0

4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one

5-Chlorothiophene-2-carboxylic acid
24065-33-6

5-Chlorothiophene-2-carboxylic acid

Rivaroxaban
366789-02-8

Rivaroxaban

Conditions
ConditionsYield
With 4-methyl-morpholine; hydrogenchloride In water; N,N-dimethyl-formamide at 20℃; for 2.83333h;95.2%
With ortho-iodophenylboronic acid In dichloromethane at 30℃; for 48h; Reagent/catalyst; Time; Concentration; Temperature; Solvent; Dean-Stark;85%
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 20℃; for 3h;68.9%
4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one
446292-10-0

4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one

N-(Benzyloxycarbonyl)sarcosine
39608-31-6

N-(Benzyloxycarbonyl)sarcosine

C25H28N4O7
947181-22-8

C25H28N4O7

Conditions
ConditionsYield
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 20℃; for 3h;92%
4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one
446292-10-0

4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one

C11H6ClN3O2S

C11H6ClN3O2S

Rivaroxaban
366789-02-8

Rivaroxaban

Conditions
ConditionsYield
With triethylamine at 10 - 25℃;90.3%
4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one
446292-10-0

4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one

4-chloro-benzoyl chloride
122-01-0

4-chloro-benzoyl chloride

4-chloro-N-{2-oxo-3-[4-(3-oxo-morpholin-4-yl)-phenyl]-oxazolidin-5-ylmethyl}-benzamide

4-chloro-N-{2-oxo-3-[4-(3-oxo-morpholin-4-yl)-phenyl]-oxazolidin-5-ylmethyl}-benzamide

Conditions
ConditionsYield
With pyridine; aminomethylpolystyrol resin at 20℃; for 3.5h;89%
4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one
446292-10-0

4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one

O-acetylsalicyloyl chloride
5538-51-2

O-acetylsalicyloyl chloride

C23H23N3O7

C23H23N3O7

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃;73%
4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one
446292-10-0

4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one

2-(methylcarbamoyl)benzoic acid.
6843-36-3

2-(methylcarbamoyl)benzoic acid.

(S)-N1-methyl-N2-((2-oxo-3-(4-(3-oxomorpholin-4-yl)phenyl)oxazolidin-5-yl)methyl)phthalamide

(S)-N1-methyl-N2-((2-oxo-3-(4-(3-oxomorpholin-4-yl)phenyl)oxazolidin-5-yl)methyl)phthalamide

Conditions
ConditionsYield
Stage #1: 2-(methylcarbamoyl)benzoic acid. With sodium hydrogencarbonate In N,N-dimethyl-formamide for 0.5h;
Stage #2: With isobutyl chloroformate In N,N-dimethyl-formamide at 0℃; for 0.5h;
Stage #3: 4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one In N,N-dimethyl-formamide for 8h;
65%
4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one
446292-10-0

4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one

(S)-2-(((2-oxo-3-(4-(3-oxomorpholin-4-yl)phenyl)oxazolidin-5-yl)methyl)carbamoyl)benzoic acid
1365267-37-3

(S)-2-(((2-oxo-3-(4-(3-oxomorpholin-4-yl)phenyl)oxazolidin-5-yl)methyl)carbamoyl)benzoic acid

N,N'-bis[{(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl}methyl]benzene-1,2-diamide
1365267-36-2

N,N'-bis[{(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl}methyl]benzene-1,2-diamide

Conditions
ConditionsYield
With 2,4,6-tripropyl-1,3,5,2,4,6-trioxatriphosphinane-2,4,6-trioxide; triethylamine In ethyl acetate; acetonitrile at 5℃; for 2.16667h; pH=8;62.8%
4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one
446292-10-0

4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one

4-nitrophenyl 5-chlorothiophene-2-carboxylate
1450877-56-1

4-nitrophenyl 5-chlorothiophene-2-carboxylate

Rivaroxaban
366789-02-8

Rivaroxaban

Conditions
ConditionsYield
With potassium carbonate In dichloromethane at 25 - 30℃;55.5%
4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one
446292-10-0

4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one

2-[2-({4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl}amino)ethoxy]acetohydrazide

2-[2-({4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl}amino)ethoxy]acetohydrazide

Conditions
ConditionsYield
With hydrazine hydrate In methanol at 80℃; for 12h; Temperature; Solvent;49.5%
With hydrazine hydrate In methanol at 80℃; for 12h;49.5%
With hydrazine hydrate In methanol at 90℃; for 12h;49.5%
4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one
446292-10-0

4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one

2-thiophenylcarboxylic acid
527-72-0

2-thiophenylcarboxylic acid

N-({(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophene-2-carboxamide

N-({(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophene-2-carboxamide

Conditions
ConditionsYield
Stage #1: 2-thiophenylcarboxylic acid With dicyclohexyl-carbodiimide In dichloromethane at 20℃; for 2h; Inert atmosphere;
Stage #2: 4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one In dichloromethane at 20℃; for 6h; Inert atmosphere;
48%
4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one
446292-10-0

4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one

(S)-4-(4-(((2-oxooxazolidin-5-yl)methyl)amino)phenyl)morpholin-3-one

(S)-4-(4-(((2-oxooxazolidin-5-yl)methyl)amino)phenyl)morpholin-3-one

Conditions
ConditionsYield
In water at 130℃; for 12h; Temperature; Time; Solvent; Autoclave;46%
With water at 130℃; for 12h; Sealed tube;46%
4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one
446292-10-0

4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one

5-chlorothien-2-ylsulfonyl chloride
2766-74-7

5-chlorothien-2-ylsulfonyl chloride

5-Chloro-thiophene-2-sulfonic acid {(R)-2-oxo-3-[4-(3-oxo-morpholin-4-yl)-phenyl]-oxazolidin-5-ylmethyl}-amide

5-Chloro-thiophene-2-sulfonic acid {(R)-2-oxo-3-[4-(3-oxo-morpholin-4-yl)-phenyl]-oxazolidin-5-ylmethyl}-amide

Conditions
ConditionsYield
With pyridine In tetrahydrofuran at 20℃; for 4h;43%
4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one
446292-10-0

4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one

bis(trichloromethyl) carbonate
32315-10-9

bis(trichloromethyl) carbonate

N,N'-bis[{(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl}methyl]urea
1365267-35-1

N,N'-bis[{(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl}methyl]urea

Conditions
ConditionsYield
Stage #1: 4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one; bis(trichloromethyl) carbonate With triethylamine In tetrahydrofuran at 20℃; Cooling;
Stage #2: With sodium carbonate In tetrahydrofuran
38.8%
4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one
446292-10-0

4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one

5-bromothiophene-2-carboxylic acid
7311-63-9

5-bromothiophene-2-carboxylic acid

5-bromo-N-({(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophene-2-carboxamide

5-bromo-N-({(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophene-2-carboxamide

Conditions
ConditionsYield
Stage #1: 5-bromothiophene-2-carboxylic acid With dicyclohexyl-carbodiimide In dichloromethane at 20℃; for 2h; Inert atmosphere;
Stage #2: 4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one In dichloromethane at 20℃; for 6h; Inert atmosphere;
37%
With benzotriazol-1-ol; N-(3-dimethylaminopropyl)-N-ethylcarbodiimide; N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 20℃;
4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one
446292-10-0

4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one

(5-fluorothiophen-2-yl)formyl chloride

(5-fluorothiophen-2-yl)formyl chloride

(S)-5-fluoro-N-((2-oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)thiophene-2-carboxamide

(S)-5-fluoro-N-((2-oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)thiophene-2-carboxamide

Conditions
ConditionsYield
With pyridine at 0 - 23℃; for 1h; Inert atmosphere;37%
4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one
446292-10-0

4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one

6-chloropicolinic acid
4684-94-0

6-chloropicolinic acid

6-chloro-N-({(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)pyridine-2-carboxamide

6-chloro-N-({(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)pyridine-2-carboxamide

Conditions
ConditionsYield
Stage #1: 6-chloropicolinic acid With dicyclohexyl-carbodiimide In dichloromethane at 20℃; for 2h; Inert atmosphere;
Stage #2: 4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one In dichloromethane at 20℃; for 6h; Inert atmosphere;
27%

(S)-4-(4-(5-(Aminomethyl)-2-oxooxazolidin-3-yl)phenyl)morpholin-3-one Specification

The 3-Morpholinone,4-[4-[(5S)-5-(aminomethyl)-2-oxo-3-oxazolidinyl]phenyl]-, with the CAS registry number 446292-10-0, is also known as (S)-4-(4-(5-(Aminomethyl)-2-oxooxazolidin-3-yl)phenyl)morpholin-3-one. This chemical's molecular formula is C14H17N3O4 and molecular weight is 291.30. Its systematic name is called 4-{4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl}morpholin-3-one.

Physical properties of 3-Morpholinone,4-[4-[(5S)-5-(aminomethyl)-2-oxo-3-oxazolidinyl]phenyl]-: (1)ACD/BCF (pH 5.5): 1; (2)ACD/BCF (pH 7.4): 1; (3)ACD/KOC (pH 5.5): 1; (4)ACD/KOC (pH 7.4): 1; (5)#H bond acceptors: 7; (6)#H bond donors: 2; (7)#Freely Rotating Bonds: 4; (8)Index of Refraction: 1.598; (9)Molar Refractivity: 73.75 cm3; (10)Molar Volume: 216 cm3; (11)Surface Tension: 57.4 dyne/cm; (12)Density: 1.348 g/cm3; (13)Flash Point: 304.8 °C; (14)Enthalpy of Vaporization: 86.82 kJ/mol; (15)Boiling Point: 580.4 °C at 760 mmHg; (16)Vapour Pressure: 1.83E-13 mmHg at 25°C.

You can still convert the following datas into molecular structure:
(1)SMILES: O=C1O[C@@H](CN)CN1c3ccc(N2C(=O)COCC2)cc3
(2)InChI: InChI=1/C14H17N3O4/c15-7-12-8-17(14(19)21-12)11-3-1-10(2-4-11)16-5-6-20-9-13(16)18/h1-4,12H,5-9,15H2/t12-/m0/s1
(3)InChIKey: DEXXSYVEWAYIGZ-LBPRGKRZBF

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View